COVID-19 Highlights Need for Public Intelligence
Hobbled by secrecy and timidity, the U.S. intelligence community has been conspicuously absent from efforts to combat the COVID-19 pandemic, the most serious national and global security challenge of our time.
The silence of intelligence today represents a departure from the straightforward approach of then-Director of National Intelligence Dan Coats who offered the clearest public warning of the risk of a pandemic at the annual threat hearing of the Senate Intelligence Committee in January 2019:
“We assess that the United States and the world will remain vulnerable to the next flu pandemic or large-scale outbreak of a contagious disease that could lead to massive rates of death and disability, severely affect the world economy, strain international resources, and increase calls on the United States for support,” DNI Coats testified.
But this year, for the first time in recent memory, the annual threat hearing was canceled, reportedly to avoid conflict between intelligence testimony and White House messaging. Though that seems humiliating to everyone involved, no satisfactory alternative explanation has been provided. The 2020 worldwide threat statement remains classified, according to an ODNI denial of a Freedom of Information Act request for a copy. And intelligence agencies have been reduced to recirculating reminders from the Centers for Disease Control to wash your hands and practice social distancing.
The US intelligence community evidently has nothing useful to say to the nation about the origins of the COVID-19 pandemic, its current spread or anticipated development, its likely impact on other security challenges, its effect on regional conflicts, or its long-term implications for global health.
These are all topics perfectly suited to open source intelligence collection and analysis. But the intelligence community disabled its open source portal last year. And the general public was barred even from that.
It didn’t — and doesn’t — have to be that way.
In 1993, the Federation of American Scientists created an international email network called ProMED — Program for Monitoring Emerging Diseases — which was intended to help discover and provide early warning about new infectious diseases.
Run on a shoestring budget and led by Stephen S. Morse, Barbara Hatch Rosenberg, Jack Woodall and Dorothy Preslar, ProMED was based on the notion that “public intelligence” is not an oxymoron. That is to say, physicians, scientists, researchers, and other members of the public — not just governments — have the need for current threat assessments that can be readily shared, consumed and analyzed. The initiative quickly proved its worth.
In fact, it has continued to prove its worth up to the present day.
“It was notices on ProMED that first alerted the world to the 2003 SARS outbreak, and it was a posting on ProMED on Dec. 30, 2019 — about chatter on the Chinese social network Weibo — that first spread word of a novel coronavirus, soon identified as the cause of COVID-19, outside China.” See “The doomed 30-year battle to stop a pandemic” by Paul Wells, Maclean’s, April 21.
ProMED, which is now managed by the International Society for Infectious Diseases, is unclassified, free, and open to subscription by anyone.
“ProMED illustrates how NGOs can, in some cases, efficiently accomplish what large, bureaucratically burdened institutions cannot even begin,” the FAS Public Interest Report said in 1996.
Today, when national and global security concerns touch almost every household, the need for public intelligence is greater than ever, and it could become one focus of a reconfigured U.S. intelligence apparatus.
A federal agency takes over 100 days on average to hire a new employee — with significantly longer time frames for some positions — compared to 36 days in the private sector.
At least 40% of Medicare beneficiaries do not have a documented AHCD. In the absence of one, medical professionals may perform major and costly interventions unknowingly against a patient’s wishes.
AI has transformative potential in the public health space, but innovation driven primarily by the private sector today may be exacerbating existing disparities by training models.
With targeted policy interventions, we can efficiently and effectively support the U.S. innovation economy through the translation of breakthrough scientific research from the lab to the market.